| Literature DB >> 27200357 |
A Noorani1, Elena Rangelova1, M Del Chiaro1, Lars Ragnar Lundell1, Christoph Ansorge1.
Abstract
BACKGROUND: Delayed gastric emptying (DGE) frequently complicates pancreatoduodenectomy (PD). Mainly DGE develops as consequence of postoperative intra-abdominal complications (secondary), while the incidence of primary DGE (i.e., not related to surgical complications) has rarely been studied. Moreover, the pathogenesis of DGE is complex and needs to be further elucidated. The present study aimed at highlighting potential mechanisms behind primary and above all secondary DGE by studying a variety of different pancreatic surgical procedures. PATIENTS AND METHODS: During the time period 2008-2011, 327 patients underwent pancreatic resective procedures at Karolinska University Hospital. Of these, 242 were PD and 56 tail resections, 17 had a duodenal preserving pancreatectomy for chronic pancreatitis, and 15 patients with familial duodenal polyposis had a pancreas preserving duodenectomy. All postoperative courses were assessed and scored according to Clavien-Dindo. The presence of DGE was evaluated and recorded according to the definition launched by the International Study Group for Pancreatic Surgery (ISGPS). Crude associations were studied in a univariate model, followed by a multivariate analysis of the respective factors. The associations were presented as odds ratios (ORs) with 95% confidence intervals (CIs).Entities:
Keywords: delayed gastric emptying; duodenectomy; pancreatic tail resection; pancreatoduodenectomy; postoperative pancreatic fistula; risk factors
Year: 2016 PMID: 27200357 PMCID: PMC4843166 DOI: 10.3389/fsurg.2016.00025
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Demographics and clinical characteristics.
| PD, | DP, | DPPHR, | PPD, | |
|---|---|---|---|---|
| Gender (M/F) | 135/107 | 26/30 | 13/4 | 7/8 |
| Mean age (years) | 65 | 62 | 48 | 48 |
| Invasive adenocarcinoma | 183 | 17 | – | |
| Neuroendocrine tumor | 13 | 16 | – | – |
| Premalignant/benign | 56 | 23 | 17 CP | 15 FAP |
| R0 resection rate | 36% | 32% | na | 100% |
| Type I diabetes | 22 | 5 | 3 | – |
| Type II diabetes | 20 | 4 | 3 | – |
| Cardiovascular morbidity | 79 | 20 | 4 | 2 |
| Other sign. comorbidity | 31 | 15 | 2 | 2 |
PD, pancreaticoduodenectomy; DP, distal pancreatectomy; DPPHR, duodenum-preserving pancreatic head resections; PPD, pancreas-preserving duodenectomy.
Postoperative courses and complications scored according to Clavien–Dindo (.
| PD, | DP, | DPPHR, | PPD, | |
|---|---|---|---|---|
| ISPG fistula | 44 | 10 | 2 | 4 |
| Grade A | 49 | 8 | 5 | 4 |
| B | 28 | 4 | 0 | 1 |
| C | 22 | 2 | 2 | 1 |
| Clavien grade 1 | 107 | 30 | 9 | 5 |
| 2 | 51 | 13 | 4 | 5 |
| 3a | 42 | 9 | 2 | 2 |
| 3b | 20 | 4 | 1 | 2 |
| 4 | 14 | 0 | 0 | 1 |
| Reoperation | 33 | 2 | 2 | 2 |
PD, pancreaticoduodenectomy; DP, distal pancreatectomy; DPPHR, duodenum-preserving pancreatic head resections; PPD, pancreas-preserving duodenectomy.
DGE subdivided into primary and secondary in the different patient groups.
| PD ( | DP ( | PPD ( | DPPHR ( | |
|---|---|---|---|---|
| Primary DGE | 47 | 7 | 1 | 2 |
| Grade A | 26 | 5 | 1 | 2 |
| B | 17 | 2 | 0 | 0 |
| C | 4 | 0 | 0 | 0 |
| Secondary DGE | 52 | 7 | 5 | 5 |
| Grade A | 23 | 3 | 3 | 3 |
| B | 11 | 2 | 1 | 0 |
| C | 18 | 2 | 1 | 2 |
| Mean post op. hospital stay (days) range | 18.5 (5–156) | 15.1 (6–77) | 16.4 (7–44) | 14.6 (6–56) |
| Mean post op. hospital stay (days) in patients without DGE | 13.7 | 12.3 | 12.7 | 9.7 |
| Mean post op. hospital stay (days) in patients with DGE | 25.4 | 23.4 | 22.0 | 21.6 |
PD, pancreaticoduodenectomy; DP, distal pancreatectomy; DPPHR, duodenum-preserving pancreatic head resections; PPD, pancreas-preserving duodenectomy.
Uni (a) and multivariate (b) analysis of risk factors for occurrence of any grade of DGE; in (c) are given corresponding data on primary DGE.
| Variables | OR | |
|---|---|---|
| Gender | 0.222 | 0.756 (0.483–1.184) |
| Age (quartiles) | 0.237 | 1.126 (0.925–1.369) |
| Diabetes | 0.161 | 0.643 (0.348–1.192) |
| BMI >30 | 0.555 | 1.206 (0.648–2.247) |
| Cardiovascular comorbidity | 0.981 | 0.933 (0.560–1.761) |
| Respiratory comorbidity | 0.145 | 0.495 (0.192–1.274) |
| Pancreatic gland risk ( | 0.000 | 1.705 (1.277–2.276) |
| Anastomotic leakage risk ( | 0.001 | 2.380 (1.411–4.013) |
| Multivisceral resection | 0.517 | 1.248 (0.638–2.439) |
| Pancreatic leakage | 0.003 | 2.366 (1.342–4.170) |
| Gender | 0.323 | 0.753 (0.429–1.322) |
| Age (quartile) | 0.087 | 1.252 (0.968–1.620) |
| Diabetes | 0.183 | 0.586 (0.267–1.286) |
| BMI ≥30 | 0.238 | 1.598 (0.734–3.048) |
| Cardiovascular comorbidity | 0.924 | 1.037 (0.494–2.175) |
| Respiratory Comorbidity | 0.217 | 0.502 (0.168–1.499) |
| Pancreatic gland risk | 0.222 | 1.596 (0.753–3.382) |
| Anastomotic leakage risk Low risk/High risk | 0.876 | 0.901 (0.244–3.334) |
| Multivisceral resection | 0.871 | 1.092 (0.378–3.157) |
| Pancreatic leakage | 0.152 | 1.752 (0.813–3.774) |
| Gender | 0.869 | 0.060 (0.531–2.012) |
| Age (quartile) | 0.104 | 1.309 (0.946–1.811) |
| Diabetes | 0.603 | 0.778 (0.302–2.006) |
| BMI ≥30 | 0.517 | 0.687 (0.221–2.138) |
| Cardiovascular comorbidity | 0.483 | 1.357 (0.578–3.186) |
| Respiratory comorbidity | 0.259 | 0.414 (0.090–1.915) |
| Pancreatic gland risk | 0.343 | 0.638 (0.252–1.0616) |
| Multivisceral resection | 0.505 | 0.589 (0.124–2.791) |